Falls and freezing of Gait in Parkinson's disease: A review of two interconnected, episodic phenomena

Movement Disorders

Volumn 19, Issue 8, 2004, Pages 871-884

  Bloem, Bastiaan R ^a   Hausdorff, Jeffrey M ^b,c   Visser, Jasper E ^a   Giladi, Nir ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TEL AVIV UNIVERSITY   (Israel)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Falls; Freezing; Gait; Parkinson's disease; Pathophysiology; Treatment

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALFACALCIDOL; ANTIOXIDANT; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; DOPAMINE RECEPTOR STIMULATING AGENT; FARNOQUINONE; FLUDROCORTISONE; LEVODOPA; MENATETRENONE; MIDODRINE; MONOAMINE OXIDASE INHIBITOR; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; THREO 3,4 DIHYDROXYPHENYLSERINE; TOCOPHEROL;

BALANCE DISORDER; BRAIN DEPTH STIMULATION; CLINICAL TRIAL; CONFUSION; DOPAMINERGIC TRANSMISSION; EPIDEMIOLOGICAL DATA; EXTRAPYRAMIDAL SYNDROME; FALLING; FRAGILITY FRACTURE; GAIT DISORDER; HALLUCINATION; HUMAN; HYPERTENSION; INCIDENCE; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MORTALITY; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; STABILOGRAPHY; STEREOTAXIC SURGERY; SURVIVAL RATE; SYMPTOMATOLOGY; SYNCOPE; TREATMENT PLANNING; WALKING AID;

ACCIDENTAL FALLS; ELECTROMYOGRAPHY; FUNCTIONAL LATERALITY; GAIT; GAIT DISORDERS, NEUROLOGIC; HUMANS; IMMOBILIZATION; MUSCULOSKELETAL EQUILIBRIUM; PARKINSON DISEASE; PHYSICAL EXAMINATION; TREATMENT OUTCOME;

EID: 4043113047     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20115     Document Type: Review

References (119)

1. Bloem BR, van Vugt JP, Beckley DJ. Postural instability and falls in Parkinson's disease. Adv Neurol 2001;87:209-223.
2. Pressley JC, Louis ED, Tang MX, et al. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 2003;60:87-93.
3. Wenning GK, Ebersbach G, Verny M, et al. Progression of falls in postmortem-confined parkinsonian disorders. Mov Disord 1999; 14:947-950.
4. Gray P, Hildebrand K. Fall risk factors in Parkinson's disease. J Neurosci Nursing 2000;32:222-228.
5. Ashburn A, Stack E, Pickering R, Ward C. Predicting fallers in a community-based sample of people with Parkinson's disease. Gerontology 2001;47:277-281.
6. Bloem BR, Grimbergen YA, Cramer M, Willemsen MD, Zwinderman AH. Prospective assessment of falls in Parkinson's disease. J Neurol 2001;248:950-958.
7. Wood BH, Bilclough JA, Bowron A, Walker R. Incidence and prediction of falls in Parkinson's disease - a prospective multi-disciplinary study. J Neurol Neurosurg Psychiatry 2002;72:721-725.
8. Kerr GK, Worringham CJ, Silburn P. Sensorimotor and clinical factors in the prediction of future falls in Parkinson disease. Proceedings of the IXth Congress of the International Society for Postural and Gait Research, Sydney, 23-28 March, 2003. Available at: http://www.powmri.unsw.edu.au/ispg2003/ISPG2003/ISPG2003.htm.
9. Stack E, Ashburn A. Fall events described by people with Parkinson's disease: implications for clinical interviewing and the research agenda. Physiother Res Int 1999;4:190-200.
10. Giladi N, McMahoon D, Przedborski S, et al. Motor blocks in Parkinson's disease. Neurology 1992;42:333-339.
11. Lamberti P, Armenise S, Castaldo V, et al. Freezing gait in Parkinson's disease. Eur Neurol 1997;38:297-301.
12. Giladi N, Mcdermott MP, Fahn S, et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 2001;56:1712-1721.
13. Giladi N, Treves TA, Simon ES, et al. Freezing of gait in patients with advanced Parkinson's disease. J Neural Transm 2001;109: 53-61.
14. Shoulson I, Oakes D, Fahn S, et al. Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial. Ann Neurol 2002;5 1: 604-612.
15. Giladi N, Kao R, Fahn S. Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord 1997;12:302-305.
16. Factor SA, Jennings DL, Molho ES, Marek KL. The natural history of the syndrome of primary progressive freezing gait. Arch Neurol 2002;59:1778-1793.
17. Hassin-Baer S, Sirota P, Korczyn AD, et al. Clinical characteristics of neuroleptic-induced parkinsonism. J Neural Transm 2001;108:1299-1308.
18. Gurevich T, Giladi N. Freezing of gait in multiple system atrophy (MSA). Parkinsonism Relat Disord 2003;9:169-174.
19. Muller J, Seppi K, Stefanova N, Poewe W, Litvan I, Wenning GK. Freezing of gait in postmortem-confirmed atypical parkinsonism. Mov Disord 2002;17:1041-1045.
20. Bloem BR, Grimbergen YA, Cramer M, Valkenburg VV. "Stops walking when talking" does not predict falls in Parkinson's disease. Ann Neurol 2000;48:268.
21. Camicioli RM, Oken BS, Sexton G, Kaye JA, Nutt JG. Verbal fluency task affects gait in Parkinson's disease with motor freezing. J Geriatr Psychiatry Neurol 1998;11:181-185.
22. Bond JM, Morris ME. Goal-directed secondary motor tasks: their effects on gait in subjects with Parkinson disease. Arch Phys Med Rehabil 2000;81:110-116.
23. Hausdorff JM, Balash J, Giladi N. Effects of cognitive challenge on gait variability in patients with Parkinson's disease. J Geriatr Psychiatry Neurol 2003;16:53-58.
24. Marchese R, Bove M, Abbruzzese G. Effect of cognitive and motor tasks on postural stability in Parkinson's disease: a posturographic study. Mov Disord 2003;18:652-658.
25. Bloem BR, Valkenburg VV, Slabbekoorn M, van Dijk JG. The Multiple Tasks Test. Strategies in Parkinson's disease. Exp Brain Res 2001;137:478-486.
26. Bloem BR, Munneke M, Carpenter MG. Allum JH. The impact of comorbid disease and injuries on resource use and expenditures in Parkinson's disease. Neurology 2003;61:1023-1024.
27. Bloem BR, van DiJk JG, Beckley DJ. Are automatic postural responses in patients with Parkinson's disease abnormal due to their stooped posture? Exp Brain Res 1999;124:481-488.
28. Burn DJ, Lees AJ. Progressive supranuclear palsy: where are we now? Lancet Neurol 2002;1:359-369.
29. van Dijk JG, Haan J, Zwinderman K, Kremer B, van Hilten JJ, Roos RA. Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity. J Neurol Neurosurg Psychiatry 1993;56:1090-1095.
30. Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST. Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology 2002;58:1247-1255.
31. Mehagnoul-Schipper DJ, Boerman RH, Hoefragels WH, Jansen RW. Effect of levodopa on orthostatic and postprandial hypotension in elderly Parkinsonian patients. J Gerontol A Biol Sci Med Sci 2001;56:M749-M755.
32. Schaafsma JD, Balash Y, Gurevich T, Bartels AL, Hausdorff JM, Giladi N. Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease. Eur J Neurol 2003; 10:391-399.
33. Rubenstein TC, Giladi N, Hausdorff JM. The power of cueing to circumvent doparmine deficits: a review of physical therapy treatment of gait disturbances in Parkinson's disease. Mov Disord 2002;17:1148-1160.
34. Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol 2001;58:1611-1615.
35. Giladi N. Freezing of gait. Clinical overview. Adv Neurol 2001; 87:191-197.
36. de Boer AGEM, Wijker W, Speelman JD, de Haes JCJM. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996;61:70-74.
37. Martinez-Martin P. An introduction to the concept of "quality of life in Parkinson's disease." J Neurol 1998; 245(Suppl. 1):S2-S6.
38. Coughlin L, Templeton J. Hip fractures in patients with Parkinson's disease. Clin Orthop Relat Res 1980;148:192-195.
39. Johnell O, Melton ILJ, Atkinson EJ, O'Fallon WM, Kurland LT. Fracture risk in patients with parkinsonism: a population based study in Olmsted County, Minnesota. Age Ageing 1992;21:32-38.
40. Adkin AL, Frank JS, Jog MS. Fear of falling and postural control in Parkinson's disease. Mov Disord 2003;18:496-502.
41. Schrag A, Jahanshahi M, Quinn NP. What contributes to depression in Parkinson's disease? Psychol Med 2001;31:65-73.
42. Sato Y, Manabe S, Kuno H, Oizumi K. Amelioration of osteopenia and hypovitaminosis D by 1 alpha-hydroxyvitamin D3 in elderly patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;66:64-68.
43. Hely MA, Morris JGL. Traficante R, Reid WGJ, O'Sullivan DJ, Williamson PM. The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry 1999;67:300-307.
44. Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998; 64:184-189.
45. Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996;334:71-76.
46. Tinetti ME, Richman D, Powell L. Falls efficacy as a measure of fear of failing. J Gerontol 1990;45:239-243.
47. Powell LE, Myers AM. The activities-specific balance confidence (ABC) scale. J Gerontol Med Sci 1995;50A:M28-M34.
48. Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn A. Construction of freezing of gait questionnaire for patients with Parkinson's disease. Parkinsonism Relat Disord 2000;6:165-170.
49. Chong RK, Barbas J, Garrison K, Herolz A, Teheng R, Sethi K. Does balance control deficit account for walking difficulty in Parkinson's disease? Int J Clin Pract 2001;55:411-412.
50. Bloem BR, Bhatia KP. Basal ganglia disorders. In: Bronstein AM, Brandt T, Nutt JG, Woollacott MH, editors. Clinical disorders of balance, posture and gait. London: Edward Arnold; 2004. p 173-206.
51. Nutt JG, Hammerstad JP, Gancher ST. Parkinson's disease: 100 maxims. London: Edward Arnold; 1992,
52. Martinez-Martin P, Urra DG, Quijano TD, et al. A new clinical tool for gait evaluation in Parkinson's disease. Clin Neuropharmacol 1997;20:183-194.
53. Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999;14:572-584.
54. Behrman AL, Light KE, Miller GM. Sensitivity of the Tinetti Gait Assessment for detecting change in individuals with Parkinson's disease. Clin Rehabil 2002;16:399-405.
55. Nieuwboer A, de Weerdt W, Dom R, Lesaffre E. A frequency and correlation analysis of motor deficits in Parkinson patients. Disabil Rehabil 1998;20:142-150.
56. Bloem BR, Visser JE, Allum JH. Posturography. In: Hallett M, editor. Handbook of clinical neurophysiology. Amsterdam: Elsevier Science BV; 2003. p 295-336.
57. Mitchell SL, Collins JJ, De Luca CJ, Burrows A, Lipsitz LA. Open-loop and closed-loop postural control mechanisms in Parkinson's disease: increased mediolateral activity during quiet standing. Neurosci Lett 1995; 197:133-136.
58. van Wegen EE, van Emmerik RE, Wagenaar RC, Ellis T. Stability boundaries and lateral postural control in Parkinson's disease. Motor Control 2001;5:254-269.
59. Rocchi L, Chiari L, Horak FB. Effects of deep brain stimulation and levodopa on postural sway in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:267-274.
60. Ebersbach G, Sojer M, Muller J, Ransmayr G, Wenning G, Poewe W. [Dysequilibrium in idiopathic Parkinson disease. The effect of cerebrovascular comorbidity]. Nervenarzt 2002;73:162-165.
61. Viitasalo MK, Kampman V, Sotaniemi KA, Leppavuori S, Myllyla VV, Korpelainen JT. Analysis of sway in Parkinson's disease using a new inclinometry-based method. Mov Disord 2002;17: 663-669.
62. Rogers MW. Disorders of posture, balance, and gait in Parkinson's disease. Clin Geriatr Med 1996;12:825-845.
63. Horak FB, Frank JS, Nutt JG. Effects of dopamine on postural control in parkinsonian subjects: scaling, set, and tone. J Neurophysiol 1996;75:2380-2396.
64. Morris ME. Movement disorders in people with Parkinson disease: a model for physical therapy. Phys Ther 2000;80:578-597.
65. Carpenter MG, Allum JH, Honegger F, Adkin AL, Bloem BR. Postural abnormalities to multidirectional stance perturbations in Parkinson's disease. I Neurol Neurosurg Psychiatry 2004 (in press).
66. Dimitrova DM, Horak FB, Nutt JG. Postural muscle responses to multidirectional translations in patients with Parkinson's disease. J Neurophysiol 2004;91:491-501.
67. Bloem BR, van Vogt JP, Beckley DJ, Reinler MP, Roos RA. Habituation of lower leg stretch reflexes in Parkinson's disease. Electroencephogr Clin Neurophysiol 1998 109:73-77.
68. Schieppati M, Nardone A. Free and supported stance in Parkinson's disease. Brain 1991; 114:1227-1244.
69. Bloem BR, Beckley DJ, van Dijk JG, Zwindemian AH. Render MP, Roos RA. Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease. Mov Disord 1996; 11:509-521.
70. Kitamura J, Nakagawa H, Iinuma K, et al. Visual influence on center of contact pressure in advanced Parkinson's disease. Arch Phys Med Rehabil 1993;74:1107-1112.
71. Allum JH Carpenter MG, Honegger F, Adkin AL, Bloem BR. Age-dependent variations in the directional sensitivity of balance corrections and compensatory arm movements in man. J Physiol (Lond) 2002;542:643-663.
72. Carpenter MG, Frank JS, Silcher CP, Peysar GW. The influence of postural threat on the control of upright stance. Exp Brain Res 2001; 138:210-218.
73. Narabayashi H, Nakamura R. Clinical neurophysiology of freezing in Parkinsonism. In: Delwaide PJ, Agnoli A, editors. Clinical neurophysiology in parkinsonism. Amsterdam: Elsevier Science Publishers BV (Biomedical Division); 1985. p 49-57.
74. Bartels AL, Balash Y, Gurevich T, Schaafsma JD, Hausdortf JM, Giladi N. Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia. J Clin Neurosci 2003;10:584-588.
75. Fahn S. The freezing phenomenon in parkinsonism. Adv Neurol 1995;67:53-63.
76. Hausdorff JM, Schaafsma JD, Balash Y, Bartels AL, Gurevich T. Giladi N. Impaired regulation of stride variability in Parkinson's disease subjects with freezing of gait. Exp Brain Res 2003:149: 187-194.
77. Hausdorff JM, Balash Y, Giladi N. Time series analysis of leg movements during freezing of gait in Parkinson's disease: akinesia, rhyme or reason? Physica A 2003;321:565-570.
78. Nieuwboer A, Dom R, de Weerdt W. Desloovere K, Fieuws S, Broens-Kaucsik E. Abnormalities of the spatiotemporal characteristics of gait at the onset of freezing in Parkinson's disease. Mov Disord 2001;16:1066-1075.
79. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001;344:710-719.
80. Iansek R, Ismail NH, Bruce M, Huxham FE, Morris ME. Frontal gait apraxia. Pathophysiological mechanisms and rehabilitation. Adv Neurol 2001;87:363-374.
81. Vidailhet M, Atchison PR, Stocchi F, Thompson PD, Rothwell JC, Marsden CD. The bereitschaftspotential preceding stepping in patients with isolated gait ignition failure. Mov Disord 1995:10: 18-21.
82. Fabre N, Brefel C, Sabatini U, et al. Normal frontal perfusion in patients with frozen gait. Mov Disord 1998;13:677-683.
83. Bloem BR, Roos RA. Neurotoxicity of designer drugs and related compounds. In: Vinken PJ, Bruyn GW, Klawans HL, de Wolff FA, editors. Handbook of clinical neurology. Vol. 21. Intoxications of the nervous system, Part II. Amsterdam: Elsevier; 1995. p 363-414.
84. Ballard PA. Tetrud JW, Langston JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 1985;35:949-956.
85. Dixit SN, Behari M, Ahuja GK. Effect of selegiline on cognitive functions in Parkinson's disease. J Assoc Physicians India 1999; 47:784-786.
86. Giladi N, Honigman S, Hocherman S. The effect of deprenyl treatment on directional and velocity control of arm movement in patients with early stages of Parkinson's disease. Clin Neuropharmacol 1999;22:54-59.
87. Schaafsma JD, Gilach N. Balash Y, Bartels AL. Gurevich T, Hausdorff JM. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci 2003;212:47-53.
88. Beckley DJ, Panzer VP, Remler MP, Ilog LB, Bloem BR. Clinical correlates of motor performance during paced postural tasks in Parkinson's disease. J Neural Sci 1995;132:133-138.
89. Frank JS, Horak FB, Nutt J. Centrally initiated postural adjustments in parkinsonian patients on and off levodopa. J Neurophysiol 2000;84:2440-2448.
90. Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 2000; 342:1484-1491.
91. Parkinson Study Group. Safety and efficacy of pramipexole in early Parkinson's disease. A randomized dose-ranging study. JAMA 1997;278:125-130.
92. Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology 1987;37:1539-1542.
93. Narabayashi N, Kondo T. Results of a doubit-blind study of L-threo-DOPS in parkinsonism. In: Fahn S, Marsden CD, Goldstein M, editors. Recent developments in Parkinson's disease. New York: MacMillan; 1987. p 279-291.
94. Tohgi H, Abe T, Takahashi S. The effects of L-threo-3,4-dihydroxyphenylserine on the total norepinephrine and dopamine concentrations in the cerebrospinal fluid and freezing gait in parkinsonian patients. J Neural Transm Park Dis Dement Sect 1993;5:27-34.
95. Stolze H, Klebe S, Poepping M, et al. Effects of bilateral subthalamic nucleus stimulation on parkinsonian gait. Neurology 2001; 57:144-146.
96. Faist M, Xie J, Kurz D, et al. Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease. Brain 2001; 124:1590-1600.
97. Bronte-Stewart HM, Minn AY, Rodrigues K, Buckley EL, Nashner LM. Postural instability in idiopathic Parkinson's disease: the role of medication and unilateral pallidotomy. Brain 2002;125: 2100-2114.
98. Maurer C, Mergner T, Xie J, Faist M, Pollak P, Lucking CH. Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease. Brain 2003;126:1146-1163.
99. Yokoyama T, Suggiyama K, Nishizawa S, Yokota N, Ohta S, Uemura K. Subthalamic nucleus stimulation for gait disturbance in Parkinson's disease. Neurosurgery 1999;45:41-47.
100. Kumar R, Lozano AM, Sime E, Halket E, Lang AE. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation. Neurology 1999;53:561-566.
101. Bakker M, Esselink RA, Renooij J, Limousin-Dowsey P, Speelman JD, Bloem BR. Effects of stereotactic neurosurgery on postural instability and gait in Parkinson's disease. Mov Disord 2004 (in press).
102. Bejjani B, Gervais D, Arnulf I, et al. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2000;68:595-600.
103. Speelman JD. Parkinson's disease and stereotaxic neurosurgery. Amsterdam: Thesis; 1991.
104. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002;125:575-583.
105. Plant RD, Jones D, Ashburn A, Lovegreen B, Handford F. Physiotherapy for people with Parkinson's disease: UK best practice. Short report. Newcastle upon Tyne: Institute of Rehabilitation; 2001.
106. Nieuwboer A, Feys P, de Weerdt W, Dom R. Is using a cue the clue to the treatment of freezing in Parkinson's disease? Physiother Res Int 1997;2:125-132.
107. Kamsma YP, Brouwer WH Lakke JPWF. Training of compensation strategies for impaired gross motor skills in Parkinson's disease. Physiother Theory Pract 1995; 11:209-229.
108. Miyai I, Fujimoto Y, Yamamoto H, et al. Long-term effect of body weight-supported treadmill training in Parkinson's disease: a randomized controlled trial. Arch Phys Med Rehabil 2002;83: 1370-1373.
109. Schenkman M. Cutson TM, Kuchibhatla M, et al. Exercise to improve spinal flexibility and function for people with Parkinson's disease: a randomized, controlled trial. J Am Geriatr Soc 1998;46:1207-1216.
110. Nieuwboer A, de Weerdt W, Dom R, Truyen M, Janssens L, Kamsma YP. The effect of a home physiotherapy program for persons with Parkinson's disease. J Rehabil Med 2001;33:266-272.
111. de Goede CJT, Keus SHJ, Kwakkel G, Wagenaar RC. The effects of physical therapy in Parkinson's disease: a research synthesis. Arch Phys Med Rehabil 2001;82:509-515.
112. Deane KH, Ellis-hill C, Jones D, et al. Systematic review of paramedical therapies for Parkinson's disease. Mov Disord 2002; 17:984-991.
113. Bloem BR, Overeem S, van Dijk JG. Syncopal falls and their mimics. In: Bronstein AM, Brandt T, Nutt JG, Woollacott MH, editors, Clinical disorders of balance, posture and gait. London: Arnold; 2004. p 286-316.
114. Wieling W, Cortelli P, Mathias CJ. Treating neurogenic orthostatic hypotension. In: Appenzeller O, editor. Handbook of clinical neurology. Vol. 75. The autonomic nervous system. Part II. Dysfunctions. Amsterdam: Elsevier; 2000. p 713-729.
115. Sato Y, Honda Y, Kaji M, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone 2002;31:114-118.
116. Giladi N. Botulinum toxin injections to one leg alleviate freezing of gait in a patient with Parkinson's disease. Mov Disord 1997; 12:1085-1086.
117. Giladi N, Gurevich T, Shabtai H, Paleacu D, Simon ES. The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study. J Neurol 2001;248: 572-576.
118. Jarman B, Hurwitz B, Cook A, Bajekal M, Lee A. Effects of community based nurses specialising in Parkinson's disease on health outcome and costs: randomised controlled trial. BMJ 2002; 324:1072-1075.
119. Trend P, Kaye J, Gage H, Owen C, Wade D. Short-term effectiveness of intensive multidisciplinary rehabilitation for people with Parkinson's disease and their caters. Clin Rehabil 2002;16: 717-725.